anti-anxiety agents

Preferred Label : anti-anxiety agents;

MeSH definition : Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.;

MeSH synonym : agents, anti-anxiety; tranquillizing agents, minor; agents, anxiolytic; anxiolytic agents; tranquilizing agents, minor; anti-anxiety drugs; agents, minor tranquilizing; minor tranquilizing agents; agents, minor tranquillizing; minor tranquillizing agents; anti anxiety drugs; drugs, anti-anxiety; anxiolytics; anti anxiety agents; Anti-Anxiety Drug; Anti Anxiety Drug; Drug, Anti-Anxiety; Anxiolytic; Anxiolytic Agent; Agent, Anxiolytic; Anti-Anxiety Agent; Agent, Anti-Anxiety; Anti Anxiety Agent;

Related MeSH term : Anti-Anxiety effect; Anti Anxiety Effect; Effect, Anti-Anxiety; Anxiolytic Effects; Effects, Anxiolytic; Antianxiety Effects; Effects, Antianxiety; Anxiolytic Effect; Effect, Anxiolytic; Anti-Anxiety Effects; Anti Anxiety Effects; Effects, Anti-Anxiety; Antianxiety Effect; Effect, Antianxiety;

MeSH annotation : note entry term ANTI-ANXIETY EFFECT: use only for the anti-anxiety effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Anxiolytic;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D014151;

UMLS CUI

C0040616;

ATC code(s)
- adinazolam [ATC Code]
- alprazolam [ATC Code]
- anxiolytics [ATC Code]
- benzodiazepine derivatives [ATC Code]
- bromazepam [ATC Code]
- buspirone [ATC Code]
- carbamates [ATC Code]
- chlordiazepoxide [ATC Code]
- diazepam [ATC Code]
- ethyl loflazepate [ATC Code]
- etifoxine [ATC Code]
- halazepam [ATC Code]
- ketazolam [ATC Code]
- lorazepam, combinations [ATC Code]
- medazepam [ATC Code]
- meprobamate, combinations [ATC Code]
- nordazepam [ATC Code]
- other anxiolytics [ATC Code]
- oxazepam [ATC Code]
- potassium clorazepate [ATC Code]
- prazepam [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Anxiolytic agent (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Antianxiety Agent [NCIt concept]
- anxiolysis [Disease (Nov.)]
- anxiolytic agent, nos [SNOMED Notion]
- anxiolytics [ATC Code]
Indexing information
- (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone [MeSH Supplementary Concept]
- 2-((2,6-dichlorobenzylidene)amino)-5,6-dihydro-4H-cyclopenta(b)thiophene-3-carbonitrile [MeSH Supplementary Concept]
- JZL 184 [MeSH Supplementary Concept]
- Khamira Gaozaban Ambri Jadwar Ood Salib Wala [MeSH Supplementary Concept]
- MRK-409 [MeSH Supplementary Concept]
- N-(2-(1-(4-chlorophenyl)-5-methoxy-1H-indole-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(1-(4-cyanobenzoyl)-5-methoxy-1H-indole-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-n-butyl-3-methoxyquinoxaline-2-carboxamide [MeSH Supplementary Concept]
- N1-(3,4-dichlorophenyl)-cyclohexane-1,2-dicarboxamide [MeSH Supplementary Concept]
- TPA-023-B [MeSH Supplementary Concept]
- cyamemazine [MeSH Supplementary Concept]
- erysothrine [MeSH Supplementary Concept]
- hydroxyphenamate [MeSH Supplementary Concept]
- imagabalin [MeSH Supplementary Concept]
- julibroside C1 [MeSH Supplementary Concept]
- shankhpushpi [MeSH Supplementary Concept]
- valyl-tyrosyl-leucyl-prolyl-arginine [MeSH Supplementary Concept]
Record concept(s)
- Anti-Anxiety agents [MeSH concept]
- Anti-Anxiety effect [MeSH concept]
See also
- GABA modulators [MeSH Descriptor]
- adrenergic beta-antagonists [MeSH Descriptor]
- anxiety [MeSH Descriptor]
- anxiety disorders [MeSH Descriptor]
See also inter- (CISMeF)
- Medicinal product acting as anxiolytic agent (product) [SNOMED CT concept]
- tranquilizer [Disease (Nov.)]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(2-pyrimidinyl)piperazine [MeSH Supplementary Concept]
- 1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one [MeSH Supplementary Concept]
- 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline [MeSH Supplementary Concept]
- 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole [MeSH Supplementary Concept]
- 6-methyl-2-(phenylethynyl)pyridine [MeSH Supplementary Concept]
- 7-nitroindazole [MeSH Supplementary Concept]
- BIBP 3226 [MeSH Supplementary Concept]
- CL 218872 [MeSH Supplementary Concept]
- Clobazam [MeSH Descriptor]
- Gabapentin [MeSH Descriptor]
- L 701324 [MeSH Supplementary Concept]
- Mirtazapine [MeSH Descriptor]
- PD 134308 [MeSH Supplementary Concept]
- PD 135158 [MeSH Supplementary Concept]
- Pregabalin [MeSH Descriptor]
- SB 206553 [MeSH Supplementary Concept]
- Vortioxetine [MeSH Descriptor]
- ZK 91296 [MeSH Supplementary Concept]
- ZK 93423 [MeSH Supplementary Concept]
- abecarnil [MeSH Supplementary Concept]
- adipiplon [MeSH Supplementary Concept]
- alnespirone [MeSH Supplementary Concept]
- alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol [MeSH Supplementary Concept]
- alpidem [MeSH Supplementary Concept]
- alprazolam [MeSH Descriptor]
- amitriptyline, chlordiazepoxide drug combination [MeSH Supplementary Concept]
- binospirone mesylate [MeSH Supplementary Concept]
- bromazepam [MeSH Descriptor]
- buspirone [MeSH Descriptor]
- butriptyline [MeSH Supplementary Concept]
- carpipramine [MeSH Supplementary Concept]
- chlordiazepoxide [MeSH Descriptor]
- chlordiazepoxide, clidinium drug combination [MeSH Supplementary Concept]
- chlormezanone [MeSH Descriptor]
- clorazepate dipotassium [MeSH Descriptor]
- deramciclane [MeSH Supplementary Concept]
- diazepam [MeSH Descriptor]
- doramectin [MeSH Supplementary Concept]
- eglumetad [MeSH Supplementary Concept]
- estazolam [MeSH Descriptor]
- ethyl loflazepate [MeSH Supplementary Concept]
- etifoxine [MeSH Supplementary Concept]
- flesinoxan [MeSH Supplementary Concept]
- fludiazepam [MeSH Supplementary Concept]
- flunitrazepam [MeSH Descriptor]
- flurazepam [MeSH Descriptor]
- fluvoxamine [MeSH Descriptor]
- gepirone [MeSH Supplementary Concept]
- halazepam [MeSH Supplementary Concept]
- honokiol [MeSH Supplementary Concept]
- indol-3-yl pyruvic acid [MeSH Supplementary Concept]
- indorenate [MeSH Supplementary Concept]
- ipsapirone [MeSH Supplementary Concept]
- kavain [MeSH Supplementary Concept]
- ketazolam [MeSH Supplementary Concept]
- lorazepam [MeSH Descriptor]
- mebikar [MeSH Supplementary Concept]
- medazepam [MeSH Descriptor]
- meprobamate [MeSH Descriptor]
- methoxytryptophol [MeSH Supplementary Concept]
- midazolam [MeSH Descriptor]
- nabilone [MeSH Supplementary Concept]
- nimetazepam [MeSH Supplementary Concept]
- nitrazepam [MeSH Descriptor]
- nordazepam [MeSH Descriptor]
- ondansetron [MeSH Descriptor]
- oxazepam [MeSH Descriptor]
- oxprenolol [MeSH Descriptor]
- pinazepam [MeSH Supplementary Concept]
- prazepam [MeSH Descriptor]
- ritanserin [MeSH Descriptor]
- suriclone [MeSH Supplementary Concept]
- tandospirone [MeSH Supplementary Concept]
- temazepam [MeSH Descriptor]
- tetrahydrodeoxycorticosterone [MeSH Supplementary Concept]
- tranylcypromine [MeSH Descriptor]
- trazodone [MeSH Descriptor]
- triazolam [MeSH Descriptor]
- triazulenone [MeSH Supplementary Concept]
- zolazepam [MeSH Descriptor]
UMLS correspondences (same concept)
- Antianxiety Agent [NCIt concept]
- Anxiolytic agent (substance) [SNOMED CT concept]
- Medicinal product acting as anxiolytic agent (product) [SNOMED CT concept]
- anxiolysis [Disease (Nov.)]
- anxiolytic agent, nos [SNOMED Notion]
- anxiolytics [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients